SCHEMBL1410156

SCHEMBL1410156

CCOC(=O)/C=C/c1ccc(-c2cccc(C(F)(F)F)c2F)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.40
ALDH1A1 P00352 4/20 0.40
TNFRSF1A P19438 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
MDM2 Q00987 1/20 0.39
NPFFR1 Q9GZQ6 2/20 0.38
NPFFR2 Q9Y5X5 2/20 0.38
CYP3A4 P08684 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 2/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1410226 0.87 PDE7A (0.44) TDP1ALDH1A1TNFRSF1AKDM4ELMNA
SCHEMBL1410093 0.85 MAPT (0.38) TDP1ALDH1A1TNFRSF1AKDM4ELMNA
SCHEMBL14300699 0.83 ALDH1A1 (0.57) TDP1ALDH1A1TNFRSF1AKDM4ELMNA
SCHEMBL14300698 0.83 ALDH1A1 (0.57) TDP1ALDH1A1TNFRSF1AKDM4ELMNA
SCHEMBL1409347 0.81 MAOB (0.41) TDP1ALDH1A1KDM4ELMNAMAPT
SCHEMBL1410090 0.78 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAMAPTCYP3A4
SCHEMBL1410150 0.77 KDM4E (0.69) ALDH1A1KDM4ELMNAMAPTPOLB
SCHEMBL1410410 0.75 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAMAPTCYP3A4
SCHEMBL1409527 0.74 FDPS (0.44) ALDH1A1KDM4ELMNAMAPTCYP3A4
SCHEMBL1410590 0.74 ALDH1A1 (0.50) ALDH1A1KDM4ELMNAMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110251187-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251187-A1 HETEROCYCLIC COMPOUND NES, BMI1, DOT1L TDP1 4453/4885ALDH1A1 270/4885TNFRSF1A 4817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.